-

Solstice Health Communications Is Now a Certified GSA Contractor

FAR HILLS, N.J.--(BUSINESS WIRE)--Solstice Health Communications is proud to announce that we are now a GSA certified government contractor (Contract 47QRAA23D006F) and able to do business with the federal government. We can help support your business needs from branding, strategy, digital activation, and all aspects of stakeholder engagement and execution.

About Solstice: Solstice offers strong strategic, medical, and creative expertise. We are a woman-owned communications agency certified by The Women’s Business Enterprise Council and are a WOSB full-service AOR. Please contact Joseph Colantoni at colantonij@solsticehc.net or visit us at www.solsticehc.net for more information.

Contacts

Joseph Colantoni
colantonij@solsticehc.net

Solstice Health Communications


Release Versions

Contacts

Joseph Colantoni
colantonij@solsticehc.net

Social Media Profiles
More News From Solstice Health Communications

Solstice HealthCommunications’ Patient Journey Work is Published in Prestigious Journal

FAR HILLS, N.J.--(BUSINESS WIRE)--Solstice, a full-service, woman-owned, communications agency is excited to announce that its patient journey project has been documented and published in the May issue of the Orphanet Journal of Rare Diseases, the portal for rare diseases and orphan drugs. “Mapping the PIK3CA-Related Overgrowth Spectrum (PROS) Patient and Caregiver Journey Using a Patient-Centered Approach” explains how Solstice used its novel methodology to develop a patient engagement roadmap...

Akron BioProducts Announces Launch of its Closed System Solutions™ line to Enable Seamless Integration of cGMP Ancillary Materials in Cell and Gene Therapy Manufacturing

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron BioProducts, a leading supplier of cGMP-compliant materials and technologies for cell and gene therapy manufacturing, today announced the launch of its Closed System Solutions™ (CSS) product line, aimed at functionally closing critical unit operations in cell and gene therapy manufacturing workflows. Akron’s industry-leading liquid Recombinant Human Interleukin-2 (rHu IL-2), Human AB Serum Converted from Octaplas®, and Human Serum Albumin 25% Solution ar...
Back to Newsroom